Business · Companies · 9 hrs ago
Diaverum and Fresenius win most of Catalonia's dialysis contract
A €498 million contract for outpatient dialysis in Catalonia has reached the proposed-award stage after a tender process that began in January 2025.
The service provides hemodialysis for people with chronic kidney failure.
Swedish company Diaverum is set to run seven of the 18 contract lots, worth €184 million.
Germany’s Fresenius, which owns Quirónsalud, is set to take six lots worth about €143 million.
The remaining lots are divided among Sistemas Renals, B. Braun and Avericum, though Avericum must provide additional documents to support its bid.
The five-year contract is budgeted at €415 million before extensions, and CatSalut must now consider the proposed awards.
Diaverum and Fresenius have been proposed as the main winners of Catalonia’s outpatient dialysis contract, valued at €498 million including extensions.
The proposed award gives Diaverum seven of 18 lots worth €184 million and Fresenius six lots worth about €143 million.
The remaining lots are divided among Sistemas Renals, B. Braun and Avericum.
The tender process began in January 2025 and was delayed by several challenges and appeals.
The contract covers five years, with a stated budget of €415 million excluding extensions.
- Who
- Diaverum and Fresenius are the main proposed winners, alongside Sistemas Renals, B. Braun and Avericum.
- What
- CatSalut’s contracting committee proposed awarding lots in a public contract for outpatient haemodialysis services.
- When
- The proposal was reported on November 17, 2026; the tender launched in January 2025.
- Where
- Catalonia, Spain.
- Why
- The contract is for outpatient haemodialysis treatment for patients with chronic kidney failure.
This story does not have two clearly opposing sides.
The tender process for Catalonia’s outpatient haemodialysis contract was launched.
The previous contract expired.
The contracting committee’s proposed awards to Diaverum and Fresenius and other operators were reported.
- Total value including extensions
- €498 million
- Contract budget
- €415 million
- Contract term
- Five years
- Diaverum
- Seven lots worth €184 million
- Fresenius
- Six lots worth about €143 million